Gilson and Funai show a preview of the soon-to-be-released Gilson Digital Dispenser. This is a non-contact dispenser capable of dispensing DMSO and aqueous solutions from pL to µL. The large dynamic range makes it ideal for dose-response studies, serial dilutions, and assay miniaturization. In this webinar, our attending experts demonstrate the functionality of the new Digital Dispenser with a cell-based assay example.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by the death of motor neurons. A hallmark of ALS is low expression of neurofilament light chain (NFL) in motor neurons. A high-throughput phenotypic assay using patient-derived induced pluripotent stem cells (iPSCs) was used to screen over 6,000 compounds. This poster demonstrates how automation of serial dilutions and dosing on PIPETMAX provides a more accurate and less labor-intensive alternative to manual pipetting for rescreening.
In environments requiring higher throughput levels, manual pipetting methods used in sample preparation, transfer, and mixing can sometimes be time-consuming and prone to procedural errors. Consider these automated liquid handling instruments if you need to increase your sampling throughput without compromising accuracy or repeatability.
Increased demand and the need for consistent results require every lab to deploy automated liquid handling in their workflows. Here’s what to consider.
The Gilson Safe Aspiration Station is a stand-alone motorized vacuum system for quick and easy aspiration of biological liquid waste disposal. Liquids are quickly and safely aspirated and collected in a 4 L polypropylene bottle. The station offers adjustable aspiration speed and handles, ideal for ELISA tests, cell culture, and any other contaminated or hazardous liquid aspiration and disposal.
In this app note, PIPETMAX, an automated pipetting platform for maximizing reproducibility of biological sample preparation, was used to demonstrate the reproducibility and accuracy for a cell-based mechanistic toxicity profiling application.
We interviewed Dr. Francesco Fiorentino, Founder and CSO of Kitos Biotech, to discuss his lab and its transition to automated liquid handling. Learn more about their story and how they have gained a competitive advantage in the market of preclinical research.